The Quality Lowdown: EU/Japan MRA, Field Alerts, Akorn, New Pfizer Plant, And The Answer Is Continuous Manufacturing

 
• By Bowman Cox

Japan and EU expand drug inspection agreement while rebuking Trump on trade; Pfizer invests tax cut in modular plant; FDA commissioner sells continuous manufacturing.

conveyer
FDA conveys the benefits of continuous manufacturing

More from Manufacturing

More from Compliance